Meeting Details
The Twentieth Annual General Meeting (20th AGM) of Eris Lifesciences Limited will be held on Friday, September 25, 2026, at 11:00 A.M. IST through video conferencing (VC) in accordance with relevant circulars issued by the Ministry of Corporate Affairs and SEBI.
The proceedings shall be deemed to be conducted at the Registered Office of the Company located at Shivarth Ambit, Plot No 142/2, Ramdas Road, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat-380054.
Business to be Transacted
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited Standalone Financial Statements along with Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026, and the reports of the Board of Directors and the Auditors thereon.
2. To appoint a Director in place of Mr. Kaushal Kamlesh Shah (DIN: 01229038) who retires by rotation and, being eligible, offers himself for re-appointment.
SPECIAL BUSINESS:
3. To ratify the remuneration of Cost Auditors for the Financial Year ending March 31, 2027, through an Ordinary Resolution proposing remuneration of Rs. 3,66,000/- to be paid to M/s. Kiran J Mehta & Co. (FRN-000025), Cost Accountants, Ahmedabad.
4. To re-appoint Mr. Sujesh Vasudevan (DIN: 08240092) as an Independent Director of the Company for a second term of five years with effect from July 25, 2027 up to July 24, 2032, through a Special Resolution.
Director Appointments Details
Mr. Kaushal Kamlesh Shah:
- DIN: 01229038
- Date of Birth: July 12, 1979 (Age ~47 years)
- Date of Appointment: October 01, 2025
- Qualification: Post graduate diploma in management
- Designation: Whole Time Director
- Remuneration: Rs. 1.68 crore during FY 2025-26
- Shareholding: 44,68,833 shares in the Company
- Board Meeting Attendance: 6 out of 6 meetings
- Other Directorships: Aprica Healthcare Limited, Eris M. J. Biopharm Private Limited, Eris Therapeutics Limited, Eris Healthcare Private Limited, Eris Pharmaceuticals Limited, Swiss Parenterals Limited, Eris Bionxt Private Limited, Talent Bridge Prosperity Foundation
Mr. Sujesh Vasudevan:
- DIN: 08240092
- Date of Birth: October 01, 1965 (Age ~60 years)
- First Term: July 25, 2022 to July 24, 2027
- Proposed Second Term: July 25, 2027 to July 24, 2032
- Qualification: Harvard Alumni, Masters in Management Studies (Mumbai), Bachelor of Pharmacy (Mumbai)
- Designation: Independent Director
- Experience: 31+ years in pharma industry across Glenmark, Abbott, and Torrent in Sales & Marketing and Business Development
- Current Roles: Senior Advisor to Boston Consulting Group (BCG), Consultant to Warburg Pincus
- Remuneration: Fee for attending meetings, reimbursement of expenses, and profit-related commission within Section 197 limits
- Shareholding: NIL shares in the Company
- Board Meeting Attendance: 7 out of 7 meetings
- Other Directorships: Eris Therapeutics Limited, Hetero Labs Limited, Entero Healthcare Solutions Limited, Ak Life Sciences Limited
Voting Arrangements
The Company has engaged MUFG Intime India Private Limited as the authorized agency for conducting the AGM and providing remote e-voting and e-voting facilities.
Remote e-voting period: Commences at 9:00 a.m. IST on Tuesday, September 22, 2026, and ends at 5:00 p.m. IST on Thursday, September 24, 2026.
Cut-off date: Friday, September 18, 2026
Results announcement: On or before Tuesday, September 29, 2026
Mr. Ravi Kapoor, Practicing Company Secretary (FCS No. 2587; COP No 2407) has been appointed as Scrutinizer for the e-voting process.
Document Availability
The Notice of the 20th AGM and the Annual Report for FY 2025-26 are available on the Company's website (https://eris.co.in/) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Limited (www.nseindia.com).
Additional Information
The Explanatory Statement pursuant to Section 102 of the Companies Act, 2013 is provided for the special business items. All documents referred to in the Notice will be available electronically for inspection by members during the AGM.